Metraipolis › archive › dc_e6213f70cb65

Epigenetic impact of endocrine-disrupting chemicals on atherosclerosis — Europe PMC PMID:40857741

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40857741
DOI
10.1042/ebc20253022
License (as archived)
solo-consultazione
Archived
2026-11-08T21:44:00.783Z
SHA-256 of the archived text
d1ffd020d96bd7fab2def8537f6956a4341a9e2c9490f8fefa8e889af7512761
Stable URL of this page
https://metraipolis.com/documento/dc_e6213f70cb65

How to cite

Epigenetic impact of endocrine-disrupting chemicals on atherosclerosis — Europe PMC PMID:40857741 — Europe PMC (en), https://europepmc.org/article/MED/40857741 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e6213f70cb65 (Metraipolis archive dc_e6213f70cb65, sha256 d1ffd020d96bd7fab2def8537f6956a4341a9e2c9490f8fefa8e889af7512761)
BibTeX
@misc{dce6213f70cb65,
  title = {Epigenetic impact of endocrine-disrupting chemicals on atherosclerosis — Europe PMC PMID:40857741},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40857741},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e6213f70cb65; sha256 d1ffd020d96bd7fab2def8537f6956a4341a9e2c9490f8fefa8e889af7512761},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40857741. Agents can read the archived copy with the MCP tool read_document.